ATAGI recommends major change to vaccine rollout Australian health authorities have recommended people under 50 receive the Pfizer vaccine rather than AstraZeneca.
AstraZeneca blood clot link increases importance of Novavax But with clinical trials progressing slowly, uncertainty remains over when Australia will access the 51 million doses of its third vaccine candidate.
Discussing contraception with young women at risk of CVD Pregnancy can increase mortality and morbidity in women with heart disease.
Research reveals mental health toll for COVID survivors One in three people who contracted COVID-19 were diagnosed with a neurological or psychiatric condition within six months of infection.
Brendan Murphy says most GPs ‘incredibly happy’ with vaccine rollout The DoH Secretary acknowledges ‘a couple of instances’ of GPs being upset receiving fewer doses, but said supply issues are to blame.
Healthcare barriers a ‘peak risk’ for transgender people Equal healthcare access has significant value for transgender and gender-diverse people, and greatly reduces mental health issues.
European regulator finds possible link between vaccine and blood clots UPDATED: The European Medicines Agency says it has found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
Research suggests men with depression are slipping through the cracks Clinicians have been advised to be on ‘very high’ alert for depression in men, especially those who present to their GP frequently.